Verax Biomedical Closes $15 Million Series B Private Placement

10/14/2005 9:00:00 AM EST

Verax Biomedical, Inc. announced that is has closed a $15 million Series B private placement with a syndicate of leading investors. Verax will use the funds to complete development and begin commercialization of its first product, the Platelet PGD test, a rapid, easy-to-use, test for the sensitive and specific detection of bacterial contamination of platelets immediately prior to transfusion.

KB Partners led the Series B financing and was joined by new investors CNF Investments, SightLine Partners, Teknoinvest, and Long River Ventures as well as existing investor BioVentures Investors. Adams Harkness acted as the exclusive placement agent and financial advisor to Verax.

(Verax's homepage)

For the press release in PDF click here

INVESTMENT IN QUNANO, THE NEW NANOTECH COMPANY IN LUND

Teknoinvest invests in QuNano AB - developer of semiconductor devices based on heterostructured nanowires

Lund, Sweden, 5 October 2005

QuNano AB announced today that it has received an investment from the Nordic venture capital firm Teknoinvest.

QuNano was founded in 2005 by Professor Lars Samuelson and his colleagues at Lund University / Lund Institute of Technology in Sweden, BTG plc, the medical innovations company headquartered in the UK and LUAB, Lund University Holding Company.  It was established to develop and commercialize promising research results covering novel nanowire hetreostructure technology from Prof. Samuelson and his team. For many years, Prof. Samuelson and his team have been in the forefront of leading nano-scale research in materials science, physics, electronics and photonics.  Since the summer of 2004, the nanowire research resulted in three publications in the world renown periodical Nature Materials (two of which were selected by Nature as "press-release of the month") and six publications in Nano Letters. The nanowire technology is the basis for a major European Integrated Project, NODE (Nanowire-based One-Dimensional Electronics), which has just been launched, with strong and active engagement from leading electronics companies like Philips, IBM and Infineon, and with the Lund team as the coordinators.

For the whole press release click here

Trolltech Secures $6.7 Million in Series B Investment Led by Index Ventures

Index's Neil Rimer Joins Trolltech's Board of Directors

OSLO, Norway - May 23 2005

Trolltech®, provider of leading technologies for Linux and cross-platform software development, today announced the completion of a $6.7 million Series B round of financing led by Index Ventures. Existing investors Teknoinvest and Northzone Ventures also participated in this round. The funding will be used to fuel Trolltech's global expansion as it capitalizes on the growing markets for embedded Linux and cross-platform desktop applications.

 
(Trolltech's homepage)

Unique aviation obstacle warning system based on Norwegian radar technology receives investment for Norwegian and U.S. market launch 

 
Teknoinvest, Viking Venture and START-fondet invest close to $ 5 million in Obstacle Collision Avoidance System (OCAS) AS. 

Oslo, Norway, May 6th 2005. OCAS AS today announced that it has attracted a venture capital investment of NOK 30 million (US$ 4.8) from Oslo based Teknoinvest and Trondheim based Viking Venture. START-fondet, which originally seed-funded OCAS, is also participating in the round.  

For the whole press release press here